Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Mediterranean Journal of Hematology and Infectious Diseases
|
May 3, 2012
A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature
Elena Elli, Caterina Cecchetti, Angelo Belotti, et al.
Leukemia Research
|
December 2, 2014
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications
Angelo Belotti, Lorena Duca, Lorenza Borin, et al.
Blood Reviews
|
April 28, 2018
Iron toxicity - Its effect on the bone marrow
Alessandro Isidori, Lorenza Borin, Elena Elli, et al.
Leukemia Research
|
June 2, 2022
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
Carolina Steidl, Andrea Aroldi, Luca Mologni, et al.
Platelets
|
December 6, 2024
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
Monica Carpenedo, Arianna Zappaterra, Lorenzo Del Castello, et al.
Leukemia Research
|
August 3, 2013
Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda"
Alfredo Molteni, Marta Riva, Annamaria Pellizzari, et al.
Scientific Reports
|
January 29, 2021
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia
Irene Motta, Dario Consonni, Marina Stroppiano, et al.
The Oncologist
|
May 22, 2024
Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study
Beatrice Manghisi, Lorenza Borin, Maria Rosaria Monaco, et al.
American Journal of Hematology
|
November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients
Barbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Leukemia Research
|
February 8, 2016
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"
Alfredo Molteni, Marta Riva, Lorenza Borin, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Mediterranean Journal of Hematology and Infectious Diseases
|
May 3, 2012
A Case of Atypical Delayed and Prolonged Hematologic Toxicity With Azacitidine in Chronic Myelomonocytic Leukemia (CMML) and Review of Literature
Elena Elli, Caterina Cecchetti, Angelo Belotti, et al.
Leukemia Research
|
December 2, 2014
Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications
Angelo Belotti, Lorena Duca, Lorenza Borin, et al.
Blood Reviews
|
April 28, 2018
Iron toxicity - Its effect on the bone marrow
Alessandro Isidori, Lorenza Borin, Elena Elli, et al.
Leukemia Research
|
June 2, 2022
Validation of a new NGS-based myeloid panel in acute myeloid leukemia: A single-center experience
Carolina Steidl, Andrea Aroldi, Luca Mologni, et al.
Platelets
|
December 6, 2024
Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience
Monica Carpenedo, Arianna Zappaterra, Lorenzo Del Castello, et al.
Leukemia Research
|
August 3, 2013
Hematological improvement during iron-chelation therapy in myelodysplastic syndromes: the experience of the "Rete Ematologica Lombarda"
Alfredo Molteni, Marta Riva, Annamaria Pellizzari, et al.
Scientific Reports
|
January 29, 2021
Predicting the probability of Gaucher disease in subjects with splenomegaly and thrombocytopenia
Irene Motta, Dario Consonni, Marina Stroppiano, et al.
The Oncologist
|
May 22, 2024
Communicating the diagnosis of a hematological neoplastic disease to patients' minor children: a multicenter prospective study
Beatrice Manghisi, Lorenza Borin, Maria Rosaria Monaco, et al.
American Journal of Hematology
|
November 16, 2012
Cytarabine and clofarabine after high-dose cytarabine in relapsed or refractory AML patients
Barbara Scappini, Giacomo Gianfaldoni, Francesco Caracciolo, et al.
Leukemia Research
|
February 8, 2016
The influence of disease and comorbidity risk assessments on the survival of MDS and oligoblastic AML patients treated with 5-azacitidine: A retrospective analysis in ten centers of the "Rete Ematologica Lombarda"
Alfredo Molteni, Marta Riva, Lorenza Borin, et al.
Page
of 3